Skip to main content
Livermore
Livermore
ZHEN

Virtus ETF Advisers LLC

SEC CIK
0001587281
Latest filing
Aug 11, 2026

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Virtus ETF Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings

Shares (Q2 2026)
44,384
Value
$1.12M
% of portfolio
0.4%
Quarters held
22
Since Q1 2021
Holdings of ACAD by Virtus ETF Advisers LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202644,384$1.12M0.4%+1,410+3.3%AddedHolders
Q1 202642,974$956.6K0.4%00.0%UnchangedHolders
Q4 202542,974$1.15M0.5%00.0%UnchangedHolders
Q3 202542,974$917.1K0.5%00.0%UnchangedHolders
Q2 202542,974$926.9K0.6%00.0%UnchangedHolders
Q1 202542,974$713.8K0.5%+22,716+112.1%AddedHolders
Q4 202420,258$371.7K0.2%−1,568−7.2%ReducedHolders
Q3 202421,826$335.7K0.2%00.0%UnchangedHolders
Q2 202421,826$354.7K0.2%+8,247+60.7%AddedHolders
Q1 202413,579$251.1K0.1%+1,954+16.8%AddedHolders
Q4 202311,625$364.0K0.2%−980−7.8%ReducedHolders
Q3 202312,605$262.7K0.2%−1,630−11.5%ReducedHolders
Q2 202314,235$340.9K0.2%−5,285−27.1%ReducedHolders
Q1 202319,520$367.4K0.2%+347+1.8%AddedHolders
Q4 202219,173$305.2K0.2%+4,680+32.3%AddedHolders
Q3 202214,493$237.0K0.1%+213+1.5%AddedHolders
Q2 202214,280$201.0K0.1%−1,892−11.7%ReducedHolders
Q1 202216,172$392.0K0.2%00.0%UnchangedHolders
Q4 202116,172$377.0K0.1%−613−3.7%ReducedHolders
Q3 202116,785$279.0K0.1%−1,545−8.4%ReducedHolders
Q2 202118,330$447.0K0.2%+6,326+52.7%AddedHolders
Q1 202112,004$310.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.